Pdt Partners, LLC Fulgent Genetics, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $320,452 - $489,067	11,984 New	11,984 $320,000
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $255,681 - $378,621	-3,415 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $228,122 - $343,036	3,415 New	3,415 $315,000
Q4 2020 Feb 16, 2021	SELL	$31.01 - $52.1 $242,498 - $407,422	-7,820 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.89 - $50.51 $124,259 - $394,988	7,820 New	7,820 $313,000
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $240,838 - $495,223	-27,091 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $182,864 - $535,047	27,091 New	27,091 $291,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.